HDAC3 and pulmonary fibrosis: On the other hand, selective inhibition of HDAC3, HDAC6 or HDAC8 has recently been demonstrated to exert remarkable therapeutic effects in the bleomycin mouse model of lung fibrosis [171,235,258].